Clinical trial
Phacotrabeculectomy With Collagen Matrix Implant (Ologen®) Versus Mitomycin C Augmented Phacotrabeculectomy: Clinical Results of a Prospective Randomized Trial
NCT03506542 is registered in ClinicalTrials.gov with Medical University of Lublin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phacotrabeculectomy With Collagen Matrix Implant (Ologen®) Versus Mitomycin C Augmented Phacotrabeculectomy: Clinical Results of a Prospective Randomized Trial
- Lead sponsor
- Medical University of Lublin
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 2, 2014
- Completion date
- March 30, 2017
- Enrollment
- 53 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.